JPMorgan Healthcare Leaders ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
JDOC price
Table
| Date | JDOC close |
|---|---|
| Oct 16, 2026 | $62.19 |
| Oct 19, 2026 | $62.08 |
| Oct 20, 2026 | $63.43 |
| Oct 21, 2026 | $63.49 |
| Oct 22, 2026 | $64.14 |
| Oct 23, 2026 | $63.67 |
| Oct 26, 2026 | $63.70 |
| Oct 27, 2026 | $63.85 |
| Oct 28, 2026 | $64.05 |
| Oct 29, 2026 | $65.34 |
| Oct 30, 2026 | $65.66 |
| Nov 2, 2026 | $65.39 |
| Nov 3, 2026 | $65.53 |
| Nov 4, 2026 | $67.57 |
| Nov 5, 2026 | $65.97 |
| Nov 6, 2026 | $66.18 |
| Nov 9, 2026 | $67.57 |
| Nov 10, 2026 | $67.58 |
| Nov 11, 2026 | $67.53 |
| Nov 12, 2026 | $67.00 |
| Nov 13, 2026 | $67.25 |
| Nov 16, 2026 | $66.93 |
Daily net flows, 1M
Net inflow over the range: +$0M
Show as table
| Label | Value ($) |
|---|---|
| Oct 13 | $0 |
| Oct 14 | $0 |
| Oct 15 | $0 |
| Oct 16 | $0 |
| Oct 19 | $0 |
| Oct 20 | $0 |
| Oct 21 | $0 |
| Oct 22 | $0 |
| Oct 23 | $0 |
| Oct 26 | $0 |
| Oct 27 | $0 |
| Oct 28 | $0 |
| Oct 29 | $0 |
| Oct 30 | $0 |
| Nov 2 | $0 |
| Nov 3 | $0 |
| Nov 4 | $0 |
| Nov 5 | $0 |
| Nov 6 | $0 |
| Nov 9 | $0 |
| Nov 10 | $0 |
| Nov 11 | $0 |
| Nov 12 | $0 |
| Nov 13 | $0 |
Flows are quiet — the past month netted out near zero, while the price has returned +15.7% so far this year. At 0.65% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 8.79% | $1431.67 | -0.8% | ||
| 2 | ABBVABBVIE | 8.38% | $294.55 | -0.2% | ||
| 3 | UNHUNITEDHEALTH GROUP | 5.32% | $412.02 | +1.1% | ||
| 4 | JNJJOHNSON & JOHNSON | 4.80% | $282.55 | -1.1% | ||
| 5 | TMOTHERMO FISHER SCIENTIFIC | 4.33% | $691.33 | -1.3% | ||
| 6 | MRKMERCK & CO | 3.53% | $144.46 | -2.2% | ||
| 7 | DHRDANAHER | 2.83% | $229.91 | -1.3% | ||
| 8 | ISRGINTUITIVE SURGICAL | 2.60% | $437.75 | -1.3% | ||
| 9 | CORCENCORA INC | 2.37% | $356.94 | -0.6% | ||
| 10 | BMYBRISTOL MYERS SQUIBB | 2.11% | $62.93 | -0.8% | ||
| 11 | SYKSTRYKER | 2.06% | $310.72 | +0.3% | ||
| 12 | IQVIQVIA HOLDINGS | 2.05% | $264.73 | -0.1% | ||
| 13 | HUMHUMANA | 1.97% | $461.25 | +2.5% | ||
| 14 | REGNREGENERON PHARMACEUTICALS | 2.02% | $952.40 | -0.3% | ||
| 15 | EWEDWARDS LIFESCIENCES | 1.95% | $107.11 | -0.0% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 54Sector weights
- Healthcare100%
- Other8.29%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Other | 8.29% |
Country weights
- United States76.29%
- Switzerland7.93%
- Other7.62%
- United Kingdom5.37%
- Denmark4.14%
- Germany2.83%
- Spain2.68%
- France2.51%
Show as table
| Item | Value (%) |
|---|---|
| United States | 76.29% |
| Switzerland | 7.93% |
| Other | 7.62% |
| United Kingdom | 5.37% |
| Denmark | 4.14% |
| Germany | 2.83% |
| Spain | 2.68% |
| France | 2.51% |
| 1 week | -0.9% |
| 1 month | +7.6% |
| 3 months | +8.3% |
| 6 months | +20.8% |
| YTD | +15.7% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | −$27K |
| 1 year | −$27K |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Dec | $0 |
| Jan | $0 |
| Feb | $0 |
| Mar | $1.4M |
| Apr | $1.4M |
| May | −$2.8M |
| Jun | $0 |
| Jul | $0 |
| Aug | $0 |
| Sep | $0 |
| Oct | $0 |
| Nov | $0 |
The top holding is 8.8% of the book; the top ten carry 49%. Spread across 51+ names, it behaves like roughly 26 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
Due diligence cuts both ways. These funds sit on the same shelf and beat JDOC on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -62bp on fee · 4137× the assets · +$917M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -62bp on fee · 1823× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.7B | +$109M | -60bp on fee · 12288× the assets · +$109M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $34B | +$587M | -61bp on fee · 3378× the assets · +$587M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$422M | -61bp on fee · 2358× the assets · +$422M in over the month | Head-to-head |


